Yastimadhu ghrita in the management of Melasma/ Mukha Vyanga
- Conditions
- Health Condition 1: L814- Other melanin hyperpigmentation
- Registration Number
- CTRI/2024/06/068670
- Lead Sponsor
- DrSapna Xavier Lopes
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Classical signs and symptoms of Vyanga like Shyava(brown coloured patches), tanuka(thin,non elevated), niruja(painless) mandalas on mukha, with or without kandu or daha or chimchimata associated with or without manasika hetus.
Subjects willing to participate and comply with all study procedures for prescribed trial period.
Subjects willing to give a written consent.
Age group between 18-55 yrs of either sex.
Subject not using any topical treatment for melasma for 2 weeks prior to enrolment to the study.
Any medical conditions, laboratory findings or physical examination findings like vital signs, outside of specific range.
If subject is on any concomitant medications like oral contraceptives, thyroid medications and hormone replacement therapies.
Known allergic reaction to component of study product.
Treatment with other investigatory drug or other intervention within a specific time frame.
H/O drug or alcohol abuse.
Pregnant and lactating women.
Subject who have taken topical or oral steroids within 1 month prior to enrolment.
Subject who have taken topical tretinoin within 3 months or topical hydroquinone within 6 months prior to enrolment.
Subject under treatment of another dermatological condition.
Post Inflammatory Hyperpigmentation(PIH).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method